Chiome Bioscience
4583.TTSE GROWTHPharmaceutical
Major holders (5%+) · 0
| Holder | Stake |
|---|
No holder currently reports 5% or more.
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 5
| Barclays Bank PLC | 4.30% |
| Growth Capital Inc. | 4.06% |
| Next Growth Inc. | 1.66% |
| Barclays Capital Securities Ltd. | 0.50% |
| Barclays Securities Japan Limited | 0.00% |
Ownership history · 47
| Holder | Ratio | Change |
|---|---|---|
| Barclays Securities Japan Limited2024-02-19 · amended | 0.00% | no change |
| Barclays Capital Securities Ltd.2024-02-19 · amended | 0.54% | +0.23pp |
| Barclays Bank PLC2024-02-19 · amended | 5.78% | no change |
| Barclays Securities Japan Limited2024-01-29 · amended | 0.00% | new |
| Barclays Capital Securities Ltd.2024-01-29 · amended | 0.31% | new |
| Barclays Bank PLC2024-01-29 · amended | 5.78% | new |
| Growth Capital Inc.2024-01-24 · amended | 4.75% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.